




Searching News Database: Acthar
HSMN NewsFeed - 13 Mar 2025
Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
HSMN NewsFeed - 5 Aug 2024
Mallinckrodt Reaches Agreement to Sell Therakos(R) Business to CVC for $925 Million
Mallinckrodt Reaches Agreement to Sell Therakos(R) Business to CVC for $925 Million
HSMN NewsFeed - 18 Jun 2018
Mallinckrodt Reports Interim Findings Of H.P. Acthar(R) Gel (Repository Corticotropin Injection) Studies
Mallinckrodt Reports Interim Findings Of H.P. Acthar(R) Gel (Repository Corticotropin Injection) Studies
HSMN NewsFeed - 14 Nov 2016
First Patient Enrolled in Mallinckrodt Phase 4 Trial of H.P. Acthar(R) Gel for Rheumatoid Arthritis
First Patient Enrolled in Mallinckrodt Phase 4 Trial of H.P. Acthar(R) Gel for Rheumatoid Arthritis
HSMN NewsFeed - 3 Nov 2010
Questcor Pharmaceuticals Launches Acthar for the Treatment of Infantile Spasms
Questcor Pharmaceuticals Launches Acthar for the Treatment of Infantile Spasms
HSMN NewsFeed - 5 Sep 2008
Questcor Strengthens Management Team's Manufacturing and Commercial Operations Capabilities
Questcor Strengthens Management Team's Manufacturing and Commercial Operations Capabilities
HSMN NewsFeed - 14 May 2007
Questcor Receives FDA Action Letter for H.P. Acthar(R) Gel for Treatment of Infantile Spasms
Questcor Receives FDA Action Letter for H.P. Acthar(R) Gel for Treatment of Infantile Spasms
Additional items found! 4

Members Archive contains
4 additional stories matching:
Acthar
(Password required)
Acthar
(Password required)